USE OF TISSUE-SPECIFIC PROMOTERS IN THE REGULATION OF AROMATASE CYTOCHROME-P450 GENE-EXPRESSION IN HUMAN TESTICULAR AND OVARIAN SEX CORD TUMORS, AS WELL AS IN NORMAL FETAL AND ADULT GONADS (VOL 77, PG 1616, 1993)
Se. Bulun et al., USE OF TISSUE-SPECIFIC PROMOTERS IN THE REGULATION OF AROMATASE CYTOCHROME-P450 GENE-EXPRESSION IN HUMAN TESTICULAR AND OVARIAN SEX CORD TUMORS, AS WELL AS IN NORMAL FETAL AND ADULT GONADS (VOL 77, PG 1616, 1993), The Journal of clinical endocrinology and metabolism, 78(2), 1994, pp. 495
We have previously demonstrated that the tissue-specific regulation of
human aromatase cytochrome P450 (P450arom) gene expression is, in par
t, the consequence of the use of tissue-specific promoters. Promoter I
.1 (PI.1) and PI.2-specific transcripts are expressed in the placenta,
whereas promoter II (PII) appears to be the only active promoter in t
he corpus luteum. Testicular and ovarian sex cord tumors with annular
tubules (SCTATs) associated with gynecomastia in prepubertal boys and
isosexual precocity in girls with Peutz-Jeghers syndrome (P-JS) have b
een previously reported. In the present study, we investigated the reg
ulatory elements directing P450arom gene transcription in samples of S
CTAT from three prepubertal boys and a girl with P-JS and an ovarian g
ranulosa cell tumor from an adult woman, as well as in healthy fetal a
nd adult testicular and ovarian tissues. Placental tissue was used as
a control. Using polymerase chain reaction linked to reverse transcrip
tion and northern blotting, we determined the tissue-specific use of v
arious P450arom promoters by analyzing specific 5'-termini from messen
ger RNA templates. Results indicate a universal gonadal promoter (PII)
directs P450arom gene expression in healthy fetal and adult ovaries a
nd testes, as well as in SCTAT of the P-JS and an adult ovarian granul
osa cell tumor. These results are interpreted to mean that use of PII
in human ovary and testis is preserved from the fetal period into adul
t life as well as in transformed neoplastic Sertoli and granulosa cell
s. On the other hand, transcripts from placenta are specific for PI.1
(and to a much lesser extent, PI.2). In SCTAT, immunoreactive P450arom
is detected only in the cytoplasm of neoplastic cells, whereas the no
rmal-appearing sex cords do not contain any immunoreactive P450arom. T
hese results further suggest that the markedly increased aromatase exp
ression of these transformed neoplastic cells is not a consequence of
using different tissue-specific promoters. Rather it appears to involv
e activation (or failure of inhibition) of the upstream regulatory ele
ments of the same promoter, which is normally functional in all gonada
l tissues, namely the proximal PII.